Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 3/20 | 0.42 |
| ▸ | MAP3K14 | Q99558 | 17/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.41 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16028669 | 0.90 | PIK3CA (0.42) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL1485257 | 0.86 | PIK3CA (0.41) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL1485127 | 0.83 | PIK3CA (0.42) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL1484978 | 0.83 | MAP3K14 (0.43) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL1485015 | 0.82 | MAP3K14 (0.44) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL15490518 | 0.82 | MAP3K14 (0.40) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL1484994 | 0.82 | MAP3K14 (0.55) | MAP3K14PIK3CDPIK3R1 | |
| SCHEMBL17613233 | 0.80 | MAP3K14 (0.42) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL1485071 | 0.78 | MAP3K14 (0.42) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG | |
| SCHEMBL19594749 | 0.78 | PIK3CA (0.42) | PIK3CAMAP3K14PIK3CDPIK3R1PIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9303043-B2 | Process for making benzoxazepin compounds | GREENTECH, INC. (US) | 2016-04-05 | — | — | US | disclosed |
| US-20140275523-A1 | PROCESS FOR MAKING BENZOXAZEPIN COMPOUNDS | GENENTECH, INC. (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275523-A1 | PROCESS FOR MAKING BENZOXAZEPIN COMPOUNDS | PIK3C2B, PIP4K2C, PIK3C2A | PIK3CA 9/4885MAP3K14 356/4885PIK3CD 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.